Hyperbaric oxygen therapy for radiation-induced brachial plexopathy | Canada Hyperbarics Skip to main content
Case Study Rep Pract Oncol Radiother 2019

Hyperbaric oxygen therapy for radiation-induced brachial plexopathy

Stowe HB, Mullins BT, Chera BS. — Rep Pract Oncol Radiother, 2019

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

Researchers reported on a case of a 45-year-old male with radiation-induced brachial plexopathy (RIBP) who received hyperbaric oxygen therapy (HBO).

What They Found

The patient developed symptoms of left brachial plexopathy 15 months after completing radiation therapy. Following 30 sessions of HBO, he reported complete pain resolution and full range of motion in his left arm within two months.

What This Means for Canadian Patients

This case suggests that hyperbaric oxygen therapy could be a potential treatment for radiation-induced brachial plexopathy, offering hope for symptom relief. Canadian patients experiencing similar complications might discuss this option with their doctors, though more research is needed.

Canadian Relevance

There is no direct Canadian connection or participant mentioned in this study.

Study Limitations

The findings of this study are limited by its single case report design, preventing generalizability.

Was this summary helpful?

Study Details

Study Type Case Study
Category Radiation Injury
Source Pubmed
PubMed ID 31762694
Year Published 2019
Journal Rep Pract Oncol Radiother

Cite This Study

Share

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.